Safety of Oral Propranolol for Infantile Hemangioma
暂无分享,去创建一个
E. Oger | A. Dupuy | R. Garlantézec | B. Guillot | J. Schleich | A. Happe | C. Droitcourt | S. Kerbrat | C. Rault | M. Botrel
[1] J. Coste,et al. Value of a national administrative database to guide public decisions: From the système national d'information interrégimes de l'Assurance Maladie (SNIIRAM) to the système national des données de santé (SNDS) in France. , 2017, Revue d'epidemiologie et de sante publique.
[2] Christine Léauté-Labrèze,et al. Infantile haemangioma , 2017, The Lancet.
[3] Ki Yong Hong,et al. Comparison of Efficacy and Safety Between Propranolol and Steroid for Infantile Hemangioma: A Randomized Clinical Trial , 2017, JAMA dermatology.
[4] Nicholas Moore,et al. The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology , 2017, Pharmacoepidemiology and drug safety.
[5] M. Lapeyre-Mestre,et al. Overview of drug data within French health insurance databases and implications for pharmacoepidemiological studies , 2016, Fundamental & clinical pharmacology.
[6] O. Boccara,et al. Safety of Oral Propranolol for the Treatment of Infantile Hemangioma: A Systematic Review , 2016, Pediatrics.
[7] S. Prey,et al. Safety of Propranolol Therapy for Severe Infantile Hemangioma. , 2016, JAMA.
[8] Mary Wu Chang,et al. A Randomized, Controlled Trial of Oral Propranolol for Infantile Hemangioma , 2015 .
[9] V. Catanzarite,et al. Prospective study of infantile haemangiomas: incidence, clinical characteristics and association with placental anomalies , 2014, The British journal of dermatology.
[10] K. Holland,et al. Initiation and Use of Propranolol for Infantile Hemangioma: Report of a Consensus Conference , 2013, Pediatrics.
[11] C. Hess,et al. Propranolol Use in PHACE Syndrome with Cervical and Intracranial Arterial Anomalies: Collective Experience in 32 Infants , 2013, Pediatric dermatology.
[12] A. Levy,et al. CNODES: the Canadian Network for Observational Drug Effect Studies , 2012, Open medicine : a peer-reviewed, independent, open-access journal.
[13] C. Hess,et al. Stroke in Children With Posterior Fossa Brain Malformations, Hemangiomas, Arterial Anomalies, Coarctation of the Aorta and Cardiac Defects, and Eye Abnormalities (PHACE) Syndrome: A Systematic Review of the Literature , 2012, Stroke.
[14] C. Hess,et al. Consensus Statement on Diagnostic Criteria for PHACE Syndrome , 2009, Pediatrics.
[15] D. Lipsker,et al. Propranolol for Severe Infantile Hemangiomas: Follow-Up Report , 2009, Pediatrics.
[16] F. Boralevi,et al. Propranolol for severe hemangiomas of infancy. , 2008, The New England journal of medicine.
[17] J. Mulliken,et al. Spastic Diplegia as a Complication of Interferon Alfa‐2a Treatment of Hemangiomas of Infancy , 1998, The Journal of pediatrics.
[18] B. Wolach,et al. Treatment of hemangiomas of infants with high doses of prednisone. , 1996, The Journal of pediatrics.